T-Cell Replete Myeloablative Haploidentical Bone Marrow Transplantation Is an Effective Option for Pediatric and Young Adult Patients With High-Risk Hematologic Malignancies

Twenty-one pediatric and young adult patients (1.1–24.7 years) with hematologic malignancies underwent myeloablative T-cell replete haploidentical bone marrow transplant (haplo-BMT) between October 2015 to December 2019. Fifty-seven percent of the patients were ethnic or racial minorities. Thirteen...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Pediatr
Главные авторы: Katsanis, Emmanuel, Sapp, Lauren N., Reid, Susie Cienfuegos, Reddivalla, Naresh, Stea, Baldassarre
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2020
Предметы:
Pediatrics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7295947/
https://ncbi.nlm.nih.gov/pubmed/32582591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2020.00282
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы